Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Claritev Corporation (CTEV : NYSE)

• Company Description    Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. Number of Employees: 3,000

• Price / Volume Information    Yesterday's Closing Price: $23.50 Daily Weekly Monthly 20 Day Moving Average: 178,482 shares Shares Outstanding: 16.95 (millions) Market Capitalization: $398.25 (millions) Beta: 0.93 52 Week High: $73.68 52 Week Low: $11.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.60% 1.66% 12 Week -0.34% -2.77% Year To Date -45.03% -50.90%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7900 TYSONS ONE PLACE SUITE 400 - MCLEAN,VA 22102 USA ph: 212-780-2000 fax: - investor@claritev.com http://www.claritev.com

• General Corporate Information    Officers Travis S. Dalton - Chief Executive Officer Douglas M. Garis - Executive Vice President and Chief Financial Offic Brock Albinson - Senior Vice President and Chief Accounting Officer Richard A. Clarke - Director Anthony Colaluca, Jr. - Director Peer Information Claritev Corporation (HLIS) Claritev Corporation (AZTA) Claritev Corporation (APYI) Claritev Corporation (RNVA) Claritev Corporation (HMSY) Claritev Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 62548M209 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/09/26 Share - Related Items Shares Outstanding: 16.95 Most Recent Split Date: 9.00 (0.03:1) Beta: 0.93 Market Capitalization: $398.25 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-3.57 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-15.13 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/09/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 1.52 Price / Sales: 0.40 EPS Growth vs. Year Ago Period: -1,190.62% vs. Previous Quarter: 20.86% Sales Growth vs. Year Ago Period: 6.59% vs. Previous Quarter: 5.23% ROE 09/30/26 - - 06/30/26 - - 03/31/26 - - ROA 09/30/26 - - 06/30/26 - -5.76 03/31/26 - -4.36 Current Ratio 09/30/26 - - 06/30/26 - 1.00 03/31/26 - 1.28 Quick Ratio 09/30/26 - - 06/30/26 - 1.00 03/31/26 - 1.28 Operating Margin 09/30/26 - - 06/30/26 - -28.19 03/31/26 - -22.06 Net Margin 09/30/26 - - 06/30/26 - -28.46 03/31/26 - -29.27 Pre-Tax Margin 09/30/26 - - 06/30/26 - -37.16 03/31/26 - -38.41 Book Value 09/30/26 - - 06/30/26 - -17.00 03/31/26 - -13.79 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Capital 09/30/26 - - 06/30/26 - - 03/31/26 - -

Powered by Zacks Investment Research ©